Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity
Yuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi · 2026
Read Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity by Yuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13560539.txt.
Description
The CRISPR-Cas13 system is a programmable gene knockdown tool widely used in basic and clinical research. Meanwhile, RNA-targeting by Cas13 exhibits collateral activity, i.e., cleavage of non-target RNAs, raising serious concerns. Accumulating evidence suggests the collateral activity comes from high expression levels of the Cas13 system. Therefore, controlled expression of the Cas13 system using viral vectors could solve the problem.
Catalog record
| CREATOR | Yuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |